Biogen agreed to pay US$300 million upfront and as much as a further US$410 million in milestone payments for BMS-986168, a Phase-2 ready drug in development for progressive supranuclear palsy (PSP).
See: (Hottod here)
While I'm still not inclined to believe the cards will fall in favour of a licence: I just don't think a Pharma will hand us big bucks to parlay NNZ 2591 (possibly the superior to the NNZ 2566 molecule, and certainly superior in the bioavailability stakes) into a gen 2 competitor.
So my leaning is to a buy-out - let's park that. I try to look beyond my assumptions and biases yada yada....
The quote above from a favoured correspondent makes a simple evidenced based assertion (read that post it's a cracker...btw) about the potential size of a deal.
And I want to pare it back to one key figure and ask what are reasonable projections to our share price?
Premise: Treagus delivers a US $300 million up front - stop there - let's say it is a licence after all...my assumption is that means that NEU gets a payment of approximately AUD $390 million. And for that, Trofinetide is with a partner, promises of royalties....etc.
If NEU had that AUD $390 million in the bank, disregarding, for now, the promise of future success and royalties, what would you put the share price at?
- Forums
- ASX - By Stock
- NEU
- An Up Front...
An Up Front...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.10 |
Change
0.000(0.00%) |
Mkt cap ! $2.569B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | $21.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.51 | 19 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 21.100 |
1 | 78 | 21.000 |
2 | 33 | 20.940 |
1 | 19 | 20.640 |
1 | 50 | 20.510 |
Price($) | Vol. | No. |
---|---|---|
19.520 | 19 | 3 |
19.830 | 40 | 2 |
20.440 | 268 | 1 |
20.500 | 1000 | 1 |
20.800 | 500 | 1 |
Last trade - 09.44am 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable